| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 06/11/2009 | US20090148512 Novel uses of chloramphenicol and analogous thereof |
| 06/11/2009 | US20090148511 Composition and method for dermatological treatment |
| 06/11/2009 | US20090148510 GPCR crystalization method using an antibody |
| 06/11/2009 | US20090148509 Encapsulation and deaggregation of polyene antibiotics using poly(ethylene glycol)-phospholipid micelles |
| 06/11/2009 | US20090148508 Methods of compositions for the treatment of ocular diseases |
| 06/11/2009 | US20090148507 Chimeric polypeptides containing chemokine domains |
| 06/11/2009 | US20090148506 Liposomal formulations comprising secondary and tertiary amines and methods for preparing thereof |
| 06/11/2009 | US20090148505 Novel Antiproliferative Factor and Methods of Use |
| 06/11/2009 | US20090148503 Topical devices and methods for assisting performance of surgical incision |
| 06/11/2009 | US20090148502 Compositions and methods for treating lacerations, abrasions, avulsions, burns, ulcers, and cases of excessive bleeding |
| 06/11/2009 | US20090148501 Process for the preparation of aromatized chewing foams for cosmetic products |
| 06/11/2009 | US20090148499 Formulation for controlled release of drugs by combining hydrophilic and hydrophobic agents |
| 06/11/2009 | US20090148498 Controlled release implantable dispensing device and method |
| 06/11/2009 | US20090148492 Method of making a vascular closure device |
| 06/11/2009 | US20090148491 Dual-Targeted Drug Carriers |
| 06/11/2009 | US20090148490 Preparation of Therapeutic Foam |
| 06/11/2009 | US20090148487 Moldable biomaterial for bone regeneration |
| 06/11/2009 | US20090148486 Compositions and methods for treating pulp inflammations caused by infection or trauma |
| 06/11/2009 | US20090148485 Controlled Release Devices and Structural Elements for Use in Their Manufacture |
| 06/11/2009 | US20090148483 Olfactory patch |
| 06/11/2009 | US20090148482 Device, System, And Method Comprising Microencapsulated Proton Donor For Release Of Nitric Oxide From A Polymer |
| 06/11/2009 | US20090148480 Sustained release preparation |
| 06/11/2009 | US20090148397 Compositions and Methods of Treatment With Proanthocyanidin Polymer Antidiarrheal Compositions |
| 06/11/2009 | US20090148390 Jucara and acai fruit-based dietary supplements |
| 06/11/2009 | US20090148389 Induction of mucosal tolerance to antigens |
| 06/11/2009 | US20090148388 Isoindoline Compounds and Methods of Making and Using the Same |
| 06/11/2009 | CA2714156A1 Oligo-ethylene glycol-based polymer compositions and methods of use |
| 06/11/2009 | CA2708064A1 Edible film |
| 06/11/2009 | CA2707568A1 Process and arrangement for producing particles utilizing subcritical fluids |
| 06/11/2009 | CA2707484A1 Improved formulations and methods for lyophilization and lyophilates provided thereby |
| 06/11/2009 | CA2707192A1 Antimelancholic medicine prepared with jujube camp materials |
| 06/11/2009 | CA2707060A1 Polysaccharide gel compositions and methods for sustained delivery of drugs |
| 06/11/2009 | CA2707013A1 Immunotherapeutic method for increasing groundnut tolerance in a subject |
| 06/11/2009 | CA2706933A1 Nanoparticles of therapeutic agents having low water solubility |
| 06/11/2009 | CA2706923A1 Intravesical compositions with valrubicin for the treatment of bladder cancer |
| 06/11/2009 | CA2706880A1 Polysaccharide gel formulation |
| 06/11/2009 | CA2706684A1 Method and arrangement for the production of particles |
| 06/11/2009 | CA2706107A1 Powder cosmetic composition |
| 06/11/2009 | CA2705131A1 Methods and compositons for enhancing the viability of microneedle pores |
| 06/10/2009 | EP2067863A2 Methods and compositions for diseases associated with amyloidosis |
| 06/10/2009 | EP2067784A2 17.beta.-carbothioate 17.alpha.-arylcarbonyloxyloxy androstane derivates as anti-flammatory agents |
| 06/10/2009 | EP2067487A2 Immunomodulatory formulations and methods for use thereof |
| 06/10/2009 | EP2067485A1 Drug carrier providing MRI contrast enhancement |
| 06/10/2009 | EP2067475A1 Tacrolimus sustained-release preparation |
| 06/10/2009 | EP2067471A1 Oral pharmaceutical dosage forms |
| 06/10/2009 | EP2067470A1 Pharmaceutical compositions containing valsartan and process for its preparation |
| 06/10/2009 | EP2067469A1 Chewable formulations |
| 06/10/2009 | EP2067468A1 Sustained release dosage forms of anesthetics for pain management |
| 06/10/2009 | EP2067466A1 Cosmetic and/or dermatological powder comprising modified starch |
| 06/10/2009 | EP2066705A1 Cationic polymers as thickeners for aqueous and alcoholic compositions |
| 06/10/2009 | EP2066666A1 Pyrazolopyridine, indazole, imidazopyridine, imidazopyrimidine, pyrazolopyrazine and pyrazolopyridine derivates as stimulators of guanylate cyclase for cardiovascular disorders |
| 06/10/2009 | EP2066350A2 Stabilized antibody formulations and uses thereof |
| 06/10/2009 | EP2066325A2 Pharmaceutical compositions of aripiprazole |
| 06/10/2009 | EP2066321A2 Treatment of asthma and chronic obstructive pulmonary disease with anti-proliferate and anti-inflammatory drugs |
| 06/10/2009 | EP2066313A2 Topical compositions |
| 06/10/2009 | EP2066310A1 Emulsions comprising rubber arabicum |
| 06/10/2009 | EP2066309A2 An oral pharmaceutical composition |
| 06/10/2009 | EP2066308A1 Multi-core solid dosage form comprising a transparent coating between said cores |
| 06/10/2009 | EP2066307A2 Rapidly disintegrating dosage form |
| 06/10/2009 | EP2066306A1 Process for preparing granules of hydrophilic vitamins |
| 06/10/2009 | EP2066305A2 Polymer matrix, method for its production, and its use |
| 06/10/2009 | EP2066304A2 Systems, methods and compositions for treatment and use of a palatal patch |
| 06/10/2009 | EP2066303A2 Method and system for treatment of eating disorders |
| 06/10/2009 | EP2066302A2 Stabilizing compositions for antibiotics and methods of use |
| 06/10/2009 | EP2066301A1 Injectable pharmaceutical nimesulide solutions |
| 06/10/2009 | EP2066300A2 Self-preserved aqueous pharmaceutical compositions |
| 06/10/2009 | EP1983978A4 Novel application of topical anesthetics for modulation of neurogenic tremor |
| 06/10/2009 | EP1802347B1 Anti-snoring composition |
| 06/10/2009 | EP1773302B1 Rapidly disintegrating gelatinous coated tablets |
| 06/10/2009 | EP1487531A4 Coated microfluidic delivery system |
| 06/10/2009 | EP1385490B1 Adhesive emulsion for medical purposes made from ethylene-vinyl acetate copolymers and adhesive resins |
| 06/10/2009 | EP1289573B1 A medicinal aerosol antidiabetics formulation |
| 06/10/2009 | EP0732924B1 Tts containing a parasympathomimetic and a parasympatholytic agent |
| 06/10/2009 | DE102007058713A1 Silicon(meth-)acrylat-Partikel, Verfahren zu deren Herstellung sowie deren Verwendung Silicone (meth) acrylate particles, processes for their preparation and their use |
| 06/10/2009 | DE102004042139B4 Perorale Darreichungsformen zur Erzielung eines Retardierungseffektes nach der Arzneimitteleinnahme mit einer Mahlzeit Oral dosage forms for obtaining a Retardierungseffektes after drug intake with a meal |
| 06/10/2009 | CN101453997A Autodestructive transdermal therapeutic system |
| 06/10/2009 | CN101453996A Drug delivery composition |
| 06/10/2009 | CN101453995A Virucidal materials |
| 06/10/2009 | CN101453994A Sustained-release alcohol-resistant multimicroparticulate oral pharmaceutical form comprising anti-misuse means |
| 06/10/2009 | CN101453993A Controlled release delivery device comprising an organosol coat |
| 06/10/2009 | CN101453992A Bilayer tablet for preventing cardiovascular events |
| 06/10/2009 | CN101453991A Process for making multiparticulates using a roller compactor |
| 06/10/2009 | CN101453990A Bupropion controllable release formulations and manufacturing process thereof |
| 06/10/2009 | CN101453989A Process for preparing spray dried formulations of TMC125 |
| 06/10/2009 | CN101453988A Glucagon-like peptide 1(glp-1) pharmaceutical formulations |
| 06/10/2009 | CN101453987A Use of polymeric materials with other substances for improved performance |
| 06/10/2009 | CN101453986A Processes and apparatuses for the production of crystalline organic microparticle compositions by micro-milling and crystallization on micro-seed and their use |
| 06/10/2009 | CN101453985A Compositions for promoting hair growth |
| 06/10/2009 | CN101453984A Compositions, methods, and kits using adenosine and inosine in combination for diagnosis and treatment |
| 06/10/2009 | CN101453983A Opioid combination wafer |
| 06/10/2009 | CN101453982A Two-piece, internal-channel osmotic delivery system flow modulator |
| 06/10/2009 | CN101450212A Solid pharmaceutical dispersions with enhanced bioavailability |
| 06/10/2009 | CN101450046A Nizatidine freeze-dried powder injection and preparation method thereof |
| 06/10/2009 | CN101450045A Freeze-drying preparation containing amphotericin B |
| 06/10/2009 | CN101450044A Anti-coccidium suspension agent containing nicarbazin and preparation technique thereof |
| 06/10/2009 | CN101450043A Soluble powder for treating poultry respiratory infection |
| 06/10/2009 | CN101450042A Soluble powder for treating livestock and poultry bacterial infection |
| 06/10/2009 | CN101450041A Nano lycorine chloride microcapsule latex and preparation method thereof |
| 06/10/2009 | CN101450040A Long-acting preparation containing taxane |
| 06/10/2009 | CN101450039A Long-acting preparation containing amphotericin B |